NERV
Minerva Neurosciences Inc
3.20$
-1.5%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 76.4% | 73.8% | 70.5% | 67.9% | 65.3% | 60.0% | 54.7% | 51.1% | 46.3% | 84.8% | 84.1% | 83.9% | |
| 74.3% | 71.9% | 69.1% | 66.9% | 62.0% | 57.5% | 52.7% | 50.1% | 43.7% | 84.0% | 34.8% | 25.9% | |
| 74.3% | 71.9% | 69.1% | 66.9% | 62.0% | 57.5% | 52.7% | 50.1% | 43.7% | 84.0% | 83.1% | 79.2% | |
| 23.6% | 26.1% | 29.4% | 32.1% | 34.7% | 40.0% | 45.3% | 48.9% | 52.9% | 15.2% | 15.8% | 15.6% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 131.8% | 150.0% | 172.4% | 196.1% | 150.6% | 169.2% | 188.9% | 205.6% | 223.1% | 243.7% | 370.1% | 312.0% | |
| 5.3% | 5.9% | 5.6% | 9.1% | 10.5% | 7.6% | 5.9% | 8.3% | 9.5% | 2.3% | 4.8% | 4.2% | |
| 2.2% | 3.2% | 2.8% | 1.8% | 1.3% | 4.3% | 2.0% | 2.9% | 3.4% | 0.7% | 2.3% | 1.5% | |
| -31.8% | -50.0% | -72.4% | -96.1% | -50.6% | -69.2% | -88.9% | -105.6% | -123.1% | -143.7% | -270.1% | -212.0% | |
| -614.3% | -697.4% | -802.6% | -893.5% | -913.5% | -1,064.4% | -1,216.9% | -1,322.8% | -1,442.2% | -703.1% | -865.9% | -837.9% | |
| 12.0% | 0.0% | 15.0% | 16.4% | 17.7% | 20.4% | 23.1% | 24.9% | 26.9% | 11.3% | 46.7% | 83.2% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.